new strokes each year
since 2017, Artiria focuses on improving minimally invasive treatment of stroke
Our technology represents a game-changer for neurovascular challenges when seconds matter and tortuosity hits. It provides an actively deformable tip and enhanced dynamic in-situ control re-sulting in seamless access to neurovascular targets. Our solution revisits the need for tip reshaping and defies the limits of navigation in complex vascular anatomies.
Artiria Medical empowers catheters and guidewires. We develop cutting edge technologies to revolutionize the limits of neurointerventional procedures, enabling a seamless navigation and stroke treatment.
Artiria Medical is the result of a passionate team willing to bring a new standard of care to neurointerventional surgeons for the benefit of their patients.
- Artiria receives FDA 510(k) clearance for Disruptive Deflectable GuidewireArtiria Medical, a Swiss neurovascular MedTech company, announces that its real-time deflectable guidewire has been granted the 510(k) clearance by the U.S. Food and Drug Administration (FDA).
- Artiria raised CHF 3.8 M to improve stroke treatmentsArtiria Medical raised CHF 3.8 M, including a CHF 2.7 M grant from the highly selective EIC accelerator program and a CHF 1.1 M bridge financing.
- ISO 13485 certificationArtiria Medical has obtained the ISO 13485 certification from TÜV SÜD for its Quality Managment System for the design and development of endovascular treatments devices.
At Artiria Medical, we are highly grateful for all the support received from our partners.
Artiria Medical has received funding from the Swiss State Secretariat for Education, Research and Innovation (SERI).